Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06020989
What this trial is testing

Lazertinib and Chemotherapy Combination in EGFR-mutant NSCLC Patients Without ctDNA Clearance After lead-in Lazertinib Monotherapy

Who this might be right for
Non Small Cell Lung Cancer
Yonsei University 129
Testing effectiveness (Phase 2)UnknownNCT04620837
What this trial is testing

Tislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line Chemotherapy

Who this might be right for
Small Cell Lung Carcinoma
Chinese Academy of Medical Sciences 25
Testing effectiveness (Phase 2)Ended earlyNCT04527900
What this trial is testing

The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach

Who this might be right for
Endometrial Cancer
University of Maryland, Baltimore 2
Early research (Phase 1)Study completedNCT00003200
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 22
Testing effectiveness (Phase 2)Looking for participantsNCT04875611
What this trial is testing

Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment

Who this might be right for
Nasopharyngeal Cancer
Maria Sklodowska-Curie National Research Institute of Oncology 32
Large-scale testing (Phase 3)Looking for participantsNCT03671044
What this trial is testing

Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Jina Pharmaceuticals Inc. 657
Not applicableStudy completedNCT05859100
What this trial is testing

Can Protein Intake be Increased Using Whole Foods Post-treatment in Cancer Patients?

Who this might be right for
CancerOther Malnutrition
University of Alberta 2
Not applicableStudy completedNCT02702830
What this trial is testing

MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment

Who this might be right for
Healthy SubjectStage IA Breast CancerStage IB Breast Cancer+5 more
Wake Forest University Health Sciences 33
Not applicableStudy completedNCT06299930
What this trial is testing

Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy

Who this might be right for
Breast Cancer
Seoul National University Hospital 10,328
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07043907
What this trial is testing

PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
Shenzhen Celconta Life Science Co., Ltd. 115
Not applicableNot Yet RecruitingNCT07822906
What this trial is testing

Risk of Esophageal Cancer Returning After Immunotherapy, Chemotherapy, and Surgery

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Peking University Cancer Hospital & Institute 100
Not applicableUnknownNCT02056548
What this trial is testing

Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy

Who this might be right for
LymphomaChronic Hepatitis B
Seoul St. Mary's Hospital 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT03806309
What this trial is testing

OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC

Who this might be right for
Pancreatic Ductal AdenocarcinomaLocally Advanced CancerMetastatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT02942355
What this trial is testing

Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer

Who this might be right for
Female Breast CarcinomaBreast Cancer
Wake Forest University Health Sciences 40
Testing effectiveness (Phase 2)UnknownNCT05895864
What this trial is testing

Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma

Who this might be right for
Metastatic Urothelial Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 34
Not applicableStudy completedNCT00897299
What this trial is testing

Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy

Who this might be right for
Breast CancerEstrogen ReceptorHer-2+1 more
Eastern Cooperative Oncology Group 900
Testing effectiveness (Phase 2)Ended earlyNCT00776100
What this trial is testing

Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 3
Not applicableNot Yet RecruitingNCT07201233
What this trial is testing

Clinical Study on the Safety and Efficacy of Umbilical Cord Blood Infusion in Treating Bone Marrow Suppression .

Who this might be right for
Bone Marrow Suppression
Shandong Qilu Stem Cells Engineering Co., Ltd. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04054167
What this trial is testing

Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Recurrent Mantle Cell LymphomaRefractory Mantle Cell Lymphoma
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT03464734
What this trial is testing

Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma

Who this might be right for
Metastatic Urothelial Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 70
Next Page